Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cancer: Information Sources for Primary Care 2 Overview Page Initiative Detail Link 4 GP Practice Profiles Outcome and process information related to cancer for every practice • NCIN Cancer Toolkit (Note: you need to register to access the NHS Version) 5 Primary Care Audit Tool Tool to support collection of cancer diagnosis data in primary care • Cancer Diagnosis Audit Tool 6 Significant Event Audit Tool to support learning around significant events related to cancer • RCGP Improving Diagnosis of Cancer 7 Referral Decision Support Tools Risk assessment tools to support cancer diagnosis and referral in primary care • Macmillan Rapid Referral Toolkit • QCancer Risk Calculator • Risk Assessment Tool 8 Safety Netting Recommendations for managing patients with potential cancer symptoms • Safety Netting Consensus Guidelines 9 Increasing screening uptake Populations least likely to attend screening • Letter template 10 Educational Tools Resources for staff and patients about cancer • Mount Vernon Cancer Network GP Education & Resource Kits • Cancer Awareness Toolkit 11 Other Sources of Information Resources relating to other aspects of cancer prevention and screening • Making Every Contact Count • RCGP Matters of Life and Death 12 Patient Information Tools Links to sources of information for patients For more information contact James Perry ([email protected]) 3 General Practice Profiles What is it? A national set of cancer metrics and metadata for every General Practice by Clinical Commissioning Group (CCG). A local GCG cancer profile trend analysis pack that accompanies this pulls key metrics from the national dataset and shows how your practice compares in relation to screening, 2WW and emergency diagnosis. Why should I use it? Reviewing the pack and the GP profiles can help your practice better understand its cancer demography and identify where your practice differs from the national and CCG average. Where can I find it? There are two versions of the national cancer profiles: Public and NHS, you can access both from this website: NCIN Cancer Toolkit Note: you have to register for the NHS website The local GP cancer profile trend analysis should have been sent with this pack, but if not please request it from [email protected] 4 Primary Care Audit Tool What is it? It is a standardised audit template for cancer to assist primary care in understanding delays in the diagnosis developed by the RCGP and NCAT . The up-to-date audit tools developed using the latest research and are available free for use by practices. Why should I use it? This is a useful tool to identify and act on delays in diagnosis and further develop understanding of cancer care. Once completed, the results can be shared with your CCG GP cancer lead so that common issues can be identified, shared with secondary care and acted upon. (See Appendix One: Audit Process) Where can I find it? For the audit template and report click here: • Cancer Diagnosis Audit Tool A national report summarising the main findings of the 2010 audit round is published here: • RCGP National Audit of Cancer Diagnosis in Primary Care 5 Significant Event Audit What is it? Practices are encouraged to use a cancer diagnosis (particularly late diagnosis) as a trigger for a Significant Event Audit (SEA). It uses a proforma specifically designed for this purpose by the RCGP and the National Patient Safety Agency. Why should I use it? The tool has been designed using information from general practice to provide a method of understanding significant events related to cancer (e.g. delayed referral, misdiagnosis etc) and provide a way of exploring the reasons behind these events. Practices may wish to share key findings with CCGs and GP Cancer Leads. Where can I find it? The report and proforma is available here: RCGP Improving Diagnosis of Cancer See: Appendix Two: Significant Event Audit 6 Referral Decision Support Tools What are they? It is recognised that diagnosis and referral for suspected cancer are rarely straightforward. A set of tools have been developed to support general practice decisions around cancer diagnosis and referral. Why should I use them? Three tools are identified below. They act as aids to support decision making around diagnosis and referral. They do not replace clinical judgement but act to aid decision making. Where can I find them? Referral Guidance can be found here: Macmillan Rapid Referral Toolkit (summary of NICE 2WW and DH direct access guidelines ) Risk Assessment Tools can be found here: QCancer Risk Calculator Risk Assessment Tool See Appendix Three for more information on the Risk Assessment Tool (RAT) 7 Safety Netting What is it? Some cancers have obvious ‘red flag symptoms’ such as a breast lump, but the majority present with vague symptoms, making early diagnosis difficult. This increases the complexity of decision making in primary care as the presenting symptoms and signs may not initially be strong enough to drive referral. Safety netting can be an important process to ensure that patients keep watch of their symptoms and know when to present back to primary care. Why should I use it? Clinicians seem to agree that the main elements of safety netting are: 1) Communicating the existence of uncertainty, 2) Outlining exactly what the patient needs to look out for, 3) How to seek further help, and 4) What to expect about time course. Currently, there is no formal consensus for how to use safety netting for cancer in primary care. Understanding the elements of safety netting is directly relevant to optimal referral and diagnostic processes, as well as patient empowerment. Where can I find more information? A national report is available here: Safety Netting Consensus Guidelines See Appendix Four for an overview of guidelines on Safety Netting 8 Increasing uptake of screening What is it? It is well recognised that there are differences in uptake of screening between different groups in our communities. There are a variety of ways to encourage uptake of screening. Why should I use them? General Practice has a responsibility to ensure that all relevant patients are encouraged to attend screening. Understanding the relative effectiveness of different ways to increase uptake of screening is important, as is knowledge of the patient groups least likely to attend, so that messages can be tailored to the audience. Where can I find more information? Practices may want to consider writing to all patients that do not attend screening clinics/send screening kits back using a sample letter template - this has been shown to increase uptake by 10%. http://pro.mountvernoncancernetwork.nhs.uk/assets/Uploads/links-anddocs/MVCNCRkitscreening-letterfinal2-4-1.doc 9 Educational Tools What are they? These are tools designed to educate primary care staff about prevention, identification and treatment of cancer. Why should I use them? Primary care staff need to be aware of the different types of cancer, prevention strategies, how to diagnose them and their treatment so that they can support patients in the best possible way. These tools provide evidenced-based information for primary care staff about cancer. Where can I find more information? There are lots of resources to educate and train primary care staff about cancer. Examples include: E-training videos and toolkits: Mount Vernon Cancer Network GP Education & Resource Kits Frontline staff training kit: Cancer Awareness Toolkit Cancer in Primary Care Toolkit and Palliative Care Module: Macmillan learnzone 10 Other sources of information • Prevention in Primary Care – Making Every Contact Count • Every member of staff should know about effective lifestyle interventions that address risk factors for cancer • The following is a useful resource: Making Every Contact Count • National Be Clear on Cancer awareness campaigns – Practices can order leaflets and posters to display during campaigns http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/materials/ Or by calling DH orderline Tel: 0300 123 1002 https://www.orderline.dh.gov.uk/ecom_dh/public/home.jsf – Briefing sheets are developed for each campaign tailored to the practice staff, nurses and GPs http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/beclearoncancer • End of life Care – Guidance from the RCGP on end of life care: RCGP Matters of Life and Death • Ovarian Cancer – Specific GP educational tools Target Ovarian 11 Patient Information Tools What are they? A range of resources are available to improve patient knowledge and action on cancer. These often focus on specific groups (i.e. young people, people who are learning disabled) and provide information in a way that is appropriate for that group. Why should I use them? These tools are useful as part of your practice’s communication strategy around cancer. They also inform staff about the best way to communicate with specific groups and remind them of important information. Where can I find more information? Some patient information tools are detailed in Appendix 5 12 For more information: Please contact: James Perry Quality Improvement Lead East of England Strategic Clinical Network [email protected] Robert Lindfield Consultant in Healthcare Public Health Anglia & Essex Centre, Public Health England [email protected] Appendices cunliffeanalytics 14 Appendix One: Primary Care Audit Process The audit process is simple and set out in the step by step guide below. Step 1: agree who will be responsible for completing the audit. (clinician and lead member of the administrative staff at minimum) Step 2: decide on the period of time to be used when identifying cases (usually 12 months, but can be less) Note: on average eight new cancers will be diagnosed per full time GP per annum. Step 3: decide on the data to be collected and identify the sources that will be used for this. This will primarily involve reviewing the patient’s record, but may include some discussion with colleagues ~ for example when considering factors related to management of the case, or possible delays in the patient’s journey. Step 4: identify all relevant patients. Assuming that all cancer diagnoses have been correctly coded, and the data entered for QOF purposes, the QOF cancer register is a useful starting point in identifying relevant cases for audit. However, it will not include patients who have recently died or left the practice, and it may be necessary to run a separate search using Read codes (codes for malignant neoplasms have a B root: B0.., B1.., B2.., etc.). Step 5: include only confirmed malignancies. Ensure that cases of carcinoma in situ and non-malignant melanoma are excluded from the audit. Step by step guide sourced from “Improving diagnosis of Cancer: a toolkit for general practice”, E Mitchell, G Rubin & U Macleod, January 2012 15 Appendix Two: Significant Event Audit Step 1: decide on the cancer sites and number of cases to be reviewed. For maximum points, QOF expects a minimum of three SEAs in a 12 month period. You should agree whether it would be most useful to consider a range of cancers, or to review the most recent diagnoses for a single site. Step 2: agree who will be responsible for carrying out the SEA(s). Although completion of the report may involve discussion with colleagues, a co-ordinator should be identified who has responsibility for undertaking the SEA. This might be the clinician who was most involved with the patient prior to the diagnosis being made. Step 3: collect as much relevant information as possible before completing the SEA report. This is likely to involve reviewing the patient’s record, and discussing the event with colleagues who may have been involved with the patient before diagnosis. Where possible this should include information on the initial presentation (including date, presenting symptom(s), duration of symptoms), GP response to initial and any ongoing symptoms, use of examination and diagnostic services, the key consultation at which the diagnosis was made, the patient’s recent presenting history, and the referral (date, type and speciality). Step 4: organise a team meeting to discuss the case(s). This should be a facilitated meeting for the purposes of shared reflection and learning. It should be structured, with basic ground rules to ensure that all opinions are valid, and that no ‘blame’ is directed at any individual(s) during the discussion. Minutes of the meeting should be taken including the key issues identified along with any related action points. These can then be circulated to all team members, including those who were not present at the meeting. Step 5: discuss the case using the four questions in the SEA report ~ “What happened?”, “Why did it happen?”, “What has been learned?”, “What has been changed”? The discussion should involve careful reflection of why events occurred as they did, as well as identification of any good aspects of care, learning needs, or changes required. Step 6: agree and implement any changes to be made. This should include identifying and agreeing on someone to oversee the changes, and to monitor these over a specified time period. This will help ensure that any alterations to practice systems and procedures are sustained beyond the short term. Step 7: complete the SEA report documentation. The report template can now be completed using the factual information collected about the case, the discussion and minutes from the team meeting, and knowledge of the implemented changes. This can then be used for QOF and/or personal appraisal. In addition, SEA reports could be shared locally. Step by step guide sourced from “Improving diagnosis of Cancer: a toolkit for general practice”, E Mitchell, G Rubin & U Macleod, January 2012 16 Appendix Three: Risk Assessment Tool (RAT) A Risk Assessment Tool (RAT) based on research by Professor Willie Hamilton in the CAPER studies (Cancer Prediction in Exeter), a series of case-control studies which identified symptoms of common cancers that presented to primary care and quantified the risk of cancer associated with them - currently lung and colorectal only. The RAT (pdf versions available on request to [email protected]) • The tool helps GPs to decide which patients below the risk level implied by NICE guidelines may benefit from urgent investigation. The risk values in the tables are the proportion of those people with the listed symptom(s) who have that cancer type. – To be used to supplement NICE guidelines – For patients aged 40 and over – To calculate the risk value: • For a single symptom, read the value from the top row • For a single symptom presented more than once, read the value from the cell on the left hand diagonal • For multiple symptoms, read the value from the cell combining the worst two symptoms – Amber and red risk values suggest 2WW referral; yellow and white may well be best managed by review within primary care, but use your clinical judgement • MacMillan are also working on a project to integrate the tool into GP systems and tables for other common cancers are currently being developed by Professor Willie Hamilton. A training video in its use is available http://www.angcn.nhs.uk/primary-care/awareness-and-early-diagnosis-primary-carepack/risk-assessment-tool.aspx See ‘Example One: Risk Assessment Tool (RAT) for Colorectal Cancer’ & ‘ Example Two: Risk Assessment Tool (RAT) for Lung Cancer’ 17 Appendix Three (continued) Example One: Risk Assessment Tool (RAT) for Colorectal Cancer Rectal bleeding Loss of Weight Abdominal pain Abdominal tenderness Abnormal rectal exam Haemoglobin 10-13g/dl Haemoglobin < 10 g/dl 0.4 0.9 2.4 1.2 1.1 1.1 1.5 0.97 2.3 Risk as a single symptom 0.8 1.1 2.4 3.0 1.5 1.7 2.6 1.2 2.6 Constipation 1.5 3.4 3.1 1.9 2.4 11 2.2 2.9 Diarrhoea 6.8 4.7 3.1 4.5 8.5 3.6 3.2 Rectal bleeding 1.4 3.4 6.4 7.4 1.3 4.7 Loss of Weight 3.0 1.4 3.3 2.2 6.9 Abdominal pain 1.7 5.8 2.7 >10 Abdominal tenderness Constipation Diarrhoea Colorectal 18 Appendix Three (continued) Example Two: Risk Assessment Tool (RAT) for Lung Cancer 1.1 1.8 1.0 2.0 1.8 1.2 1.6 1.2 4.0 2.3 1.4 1.5 2.7 3.6 1.8 2.8 2.3 5.5 7.6 5.0 2.7 4.2 6.5 2.4 2.4 >10 >10 * 2.4 2.0 3.3 4.9 5.0 9.2 >10 >10 >10 17 Risk as a single symptom Cough Fatigue Dyspnoea Chest pain Loss of weight Loss of appetite Thrombocytosis Abn. spirometry Haemoptysis Haemoptysis 2.1 2.3 2.0 3.1 4.4 1.7 Abnormal spirometry Loss of weight 1.3 0.9 1.3 2.2 1.4 Thrombocytosis 1.6 2.0 1.8 2.0 2.0 6.1 0.9 1.2 1.4 1.4 1.5 Loss of appetite 0.9 1.6 1.2 2. 0 1.8 2.3 1.7 Abnormal spirometry Thrombocytosis 0.8 0.8 0.8 1.2 0.9 Loss of appetite 0.7 0.8 0.9 0.9 Loss of weight 0.4 0.6 0.56 Chest pain Fatigue 0.4 0.6 Dyspnoea Cough Lung Cancer Assessment Tool for Non –Smokers Chest pain 0.8 1.0 1.2 Dyspnoea Fatigue 0.9 1.3 Haemoptysis Cough Lung Cancer Assessment Tool for Smokers 4.0 3.6 >10 >10 >10 >10 * * 4.5 3.9 6.1 6.9 4.1 * * 12 Risk as a single symptom Cough Fatigue Dyspnoea Chest pain Loss of weight Loss of appetite Haemoptysis * The original study was not able to calculate figures for these boxes, but they are almost certainly red. 19 Appendix Four: Safety netting advice recommendations Recommended safety netting information to communicate to the patient High Priority Cancer Safety Netting Advice (Include in patient communication) The likely time course (time to resolution of self-limiting condition) of current symptoms (e.g. cough, bowel symptoms, pain) Specific information about when and how to re-consult if symptoms do not resolve in the expected time course Specific warning symptoms and signs of serious disease (e.g. cancer) Who should make a follow up appointment with the GP, if needed (usually requesting the patient make the appointment, sometimes the doctor) Intermediate Priority (Consider including in patient communication ) If a diagnosis is uncertain, give a clear explanation for the reasons for tests or investigations (e.g. to exclude the possibility of serious disease or cancer) If a diagnosis is uncertain, that uncertainty should be communicated to the patient Recommended safety netting actions that GPs should take during or shortly after the consultation Recommended safety netting actions for Practices. High Priority Cancer Safety Netting Advice (Include in consultations) The practice should have procedures in place to ensure that patients are aware of how to obtain results of investigations Safety net advice should be documented in the medical notes Practices should ensure that current contact details are available for patients undergoing tests/investigations or referrals The practice should have a system for communicating abnormal test results to patients Practices should have a system for contacting patients with abnormal test results who fail to attend for follow up High Priority (Ensure reliable practice systems are in place) GPs should consider referral after repeated consultations for the same symptom where the diagnosis is uncertain (e.g. three strikes and you are in). The GP should ensure that the patient understands the safety netting advice GPs should take additional measures to ensure that safety netting advice is understood in patients with language and literacy barriers GPs should keep up to date on current guidelines for urgent referral for suspected cancer Intermediate Priority (Consider including in consultations) If symptoms do not resolve, further investigations should be conducted even if previous tests are negative Safety netting advice should be given verbally High Priority Cancer Safety Netting Advice – (Ensure patient communication procedures are in place) Practice systems should be in place to document that all results have been viewed, and acted upon appropriately Practices should have policies in place to ensure that tests/investigations ordered by locums are followed up Practices should conduct significant event analysis for delayed diagnoses of cancer (focusing on symptoms, signs, diagnostic procedures, continuity of care and reasons for delay) Intermediate Priority (Consider using reliable practice systems) Practice systems should be able to highlight repeat consultations for unexplained recurrent symptoms/signs Practices should conduct an annual audit of new cancer diagnoses Practices should participate in cancer awareness campaigns Practice staff involved in processing /logging of results should be aware of reasons for urgent referral under the 2 week wait 20 Appendix Five: Patient Information • The following pages give a list of websites that provide information about cancer for patients. • The list is not exhaustive. We welcome feedback about these and other websites you find useful. • We suggest that you are aware of the information contained on the websites before recommending them to patients. • We have only listed websites from recognised organisations (Cancer Research UK, NHS Choices, Macmillan) that focus on evidence-based interventions. • We have not reviewed each and every resource so cannot vouch for their quality. 21 Appendix Five (continued) Prevention and Early Detection Website with information about cancer prevention http://www.nhs.uk/LiveWell/preventing-cancer/Pages/Preventing-cancerhome.aspx Interactive tool to support health living choices related to cancer prevention http://www.cancerresearchuk.org/cancer-info/healthyliving/ Interactive tool to aid risk assessment of early cancer http://www.cancerresearchuk.org/cancer-info/spotcancerearly/ Interactive tool to aid risk assessment of cancerous moles http://www.nhs.uk/Tools/Pages/moleassessment.aspx Interactive tool to aid risk assessment of ovarian http://www.nhs.uk/Tools/Pages/ovarian-cancersymptoms.aspx?Tag=Female+health cancer Interactive tool to aid risk assessment of bowel cancer http://www.nhs.uk/Tools/Pages/Bowel-cancer-selfassessment.aspx?Tag=Screening+and+tests 22 Appendix Five (continued) General Information about Cancer Webpage with information about the results of tests for cancer (including staging) http://www.nhs.uk/Livewell/cancer/Pages/Understandingyourresults .aspx Website with extensive list of cancers with links to information on each cancer http://www.cancerresearchuk.org/cancer-help/type/ Information for Young People with Cancer Website for young people (19-24) who have been diagnosed with cancer. http://www.nhs.uk/young-cancer-care/pages/index.aspx Information about cancer for people who are learning disabled A video guide to breast screening for anyone http://www.nhs.uk/Tools/Pages/Your-guide-to-breast-screeningvideo-wall.aspx?Tag=Female+health with a learning disability A list of resources about cancer and end-oflife for people who are learning disabled (Note: some of these have to be ordered and are not free) http://www.cancerresearchuk.org/cancer-help/about-cancer/cancerquestions/books-on-cancer-for-people-with-learning-disabilities Information on cancer for people who do not speak English Cancer information leaflets in ten different languages http://www.macmillan.org.uk/Cancerinformation/Otherformats/Forei gn.aspx